Center of Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Center of Clinical Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Mov Disord. 2021 May;36(5):1170-1179. doi: 10.1002/mds.28467. Epub 2021 Jan 12.
New noninvasive and affordable molecular approaches that will complement current practices and increase the accuracy of Parkinson's disease (PD) diagnosis are urgently needed. Circular RNAs (circRNAs) are stable noncoding RNAs that accumulate with aging in neurons and are increasingly shown to regulate all aspects of neuronal development and function.
Τhe aims of this study were to identify differentially expressed circRNAs in blood mononuclear cells of patients with idiopathic PD and explore the competing endogenous RNA networks affected.
Eighty-seven circRNAs were initially selected based on relatively high gene expression in the human brain. More than half of these were readily detectable in blood mononuclear cells using real-time reverse transcription-polymerase chain reaction. Comparative expression analysis was then performed in blood mononuclear cells from 60 control subjects and 60 idiopathic subjects with PD.
Six circRNAs were significantly down-regulated in patients with PD. The classifier that best distinguished PD consisted of four circRNAs with an area under the curve of 0.84. Cross-linking immunoprecipitation-sequencing data revealed that the RNA-binding proteins bound by most of the deregulated circRNAs include the neurodegeneration-associated FUS, TDP43, FMR1, and ATXN2. MicroRNAs predicted to be sequestered by most deregulated circRNAs have the Gene Ontology categories "protein modification" and "transcription factor activity" mostly enriched.
This is the first study that identifies specific circRNAs that may serve as diagnostic biomarkers for PD. Because they are highly expressed in the brain and are derived from genes with essential brain functions, they may also hint on the PD pathways affected. © 2021 Biomedical Research Foundation, Academy of Athens. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
新的非侵入性和经济实惠的分子方法将补充当前的实践,并提高帕金森病(PD)诊断的准确性,这是迫切需要的。环状 RNA(circRNA)是稳定的非编码 RNA,随着神经元的衰老而积累,并且越来越多地被证明可以调节神经元发育和功能的各个方面。
本研究的目的是鉴定特发性 PD 患者血液单核细胞中差异表达的 circRNA,并探讨受影响的竞争内源性 RNA 网络。
最初根据人脑中的相对高基因表达选择了 87 个 circRNA。使用实时逆转录-聚合酶链反应,超过一半的 circRNA 可在血液单核细胞中轻易检测到。然后在 60 名对照受试者和 60 名特发性 PD 受试者的血液单核细胞中进行比较表达分析。
在 PD 患者中,有 6 个 circRNA 明显下调。区分 PD 的最佳分类器由四个具有 0.84 曲线下面积的 circRNA 组成。交联免疫沉淀测序数据显示,大多数下调的 circRNA 结合的 RNA 结合蛋白包括与神经退行性变相关的 FUS、TDP43、FMR1 和 ATXN2。大多数下调的 circRNA 可能被 sequestered 的 microRNAs 具有“蛋白质修饰”和“转录因子活性”的主要富集的基因本体类别。
这是第一项鉴定可能作为 PD 诊断生物标志物的特定 circRNA 的研究。由于它们在大脑中高度表达,并且源自具有重要大脑功能的基因,它们也可能暗示受影响的 PD 途径。©2021 生物医学研究基金会,雅典科学院。运动障碍由 Wiley 期刊代表国际帕金森和运动障碍协会出版。